EXTENDED REPORT

Mortality in patients with rheumatoid arthritis treated actively from the time of diagnosis

R Peltomaa¹, L Paimela², H Kautiainen³, M Leirisalo-Repo¹

¹ Division of Rheumatology, Department of Medicine, Helsinki University Hospital, Helsinki, Finland
² Orton Hospital, Invalid Foundation, Helsinki, Finland
³ Rheumatism Foundation Hospital, Heinola, Finland

Correspondence to:
Correspondence to:
Dr R Peltomaa, Division of Rheumatology, Department of Medicine, Helsinki University Central Hospital, Kasarmikatu 11–13, PO Box 263, FIN-00029 HUS, Finland;
Ritva.Peltomaa{at}hus.fi

Objectives: To evaluate the mortality rates among patients with early rheumatoid arthritis (RA) treated actively according to the "sawtooth" strategy.

Methods: The study included 150 early, disease modifying antirheumatic drug (DMARD) naive patients with RA from two patient cohorts. The first cohort was assembled between 1986 and 1989 (87 patients, aged 19–65 years at onset) and the second between 1991 and 1993 (63 patients, aged 27–83 years at onset). The mean duration of symptoms at the time of diagnosis was 7.1 months (range 2–24). The clinical data and the use of DMARDs were systematically recorded. The causes of death were obtained from death certificates and medical records, if available. The data were collected up to 1 November 2000.

Results: During a follow up time of 7–14 years, 24 patients died. The standardised mortality ratio was not increased (0.93 in the first cohort and 1.62 in the second cohort). Age adjusted mortality rates did not differ statistically significantly between the two patient cohorts. The causes of death included malignancy (8 patients); cardiovascular diseases (10); respiratory disease (4), including two patients with pneumonia; sepsis (one); and RA (one). High inflammatory activity, disease activity, and poor functional ability at study entry, and the presence of extra-articular features during the follow up were more common among the patients who had died.

Conclusions: No statistically significant increase in mortality rates was seen in these actively treated early RA cohorts during the follow up. High disease activity at the onset and the development of extra-articular features seem to be associated with mortality.

Keywords: early rheumatoid arthritis; mortality; treatment

Abbreviations: ARA, American Rheumatism Association; CI, confidence interval; DMARD, disease modifying antirheumatic drug; ESR, erythrocyte sedimentation rate; HAQ, Health Assessment Questionnaire; NSAID, non-steroidal anti-inflammatory drug; RA, rheumatoid arthritis; SMR, standardised mortality ratio

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• ABELSON, B., SOKKA, T., PINCUS, T. (2009). Declines in Erythrocyte Sedimentation Rates in Patients with Rheumatoid Arthritis Over the Second Half of the 20th Century. The Journal of Rheumatology 36: 1596-1599 [Abstract] [Full Text]  
• Egan, C. G., Caporali, F., Garcia-Gonzalez, E., Galeazzi, M., Sorrentino, V. (2008). Endothelial progenitor cells and colony-forming units in rheumatoid arthritis: association with clinical characteristics. Rheumatology (Oxford) 47: 1484-1488 [Abstract] [Full Text]  
• Farragher, T. M, Lunt, M., Bunn, D. K, Silman, A. J, Symmons, D. P M (2007). Early functional disability predicts both all-cause and cardiovascular mortality in people with inflammatory polyarthritis: results from the Norfolk Arthritis Register. Ann Rheum Dis 66: 486-492 [Abstract] [Full Text]  
• Young, A., Koduri, G., Batley, M., Kulinskaya, E., Gough, A., Norton, S., Dixey, J., on behalf of the Early Rheumatoid Arthritis Study, (2007). Mortality in rheumatoid arthritis. Increased in the early course of disease, in ischaemic heart disease and in pulmonary fibrosis. Rheumatology (Oxford) 46: 350-357 [Abstract] [Full Text]  
• Goodson, N, Marks, J, Lunt, M, Symmons, D (2005). Cardiovascular admissions and mortality in an inception cohort of patients with rheumatoid arthritis with onset in the 1980s and 1990s. Ann Rheum Dis 64: 1595-1601 [Abstract] [Full Text]  
• Hakoda, M, Oiwa, H, Kasagi, F, Masunari, N, Yamada, M, Suzuki, G, Fujiwara, S (2005). Mortality of rheumatoid arthritis in Japan: a longitudinal cohort study. Ann Rheum Dis 64: 1451-1455 [Abstract] [Full Text]  
• Gerli, R, Goodson, N J (2005). Cardiovascular involvement in rheumatoid arthritis. Lupus 14: 679-682 [Abstract]